Valuation: Kim Forest Enterprise Co., Ltd.

Market Cap 812M 25.19M 21.84M 20.45M 18.71M 35.26M 2.4B 35.86M 239M 93.89M 1.2B 94.59M 92.53M 3.99B P/E 2024
-7.91x
P/E 2025 -7.34x
Enterprise Value 1.07B 33.26M 28.84M 27M 24.7M 46.56M 3.16B 47.35M 316M 124M 1.58B 125M 122M 5.27B EV / Sales 2024
2.86x
EV / Sales 2025 2.43x
Free-Float
43.95%
Yield 2024 *
-
Yield 2025 -
1 day+3.46%
1 week+0.37%
Current month+0.75%
1 month-13.50%
3 months+5.08%
6 months-24.44%
Current year-24.01%
1 week 11.75
Extreme 11.75
14.05
1 month 11.75
Extreme 11.75
16.45
Current year 11.4
Extreme 11.4
18.5
1 year 11.4
Extreme 11.4
26.45
3 years 11.4
Extreme 11.4
48.1
5 years 11.4
Extreme 11.4
50.38
10 years 8.27
Extreme 8.27329
122.57
Manager TitleAgeSince
Chief Executive Officer - 30/06/2005
Director of Finance/CFO - 01/12/2013
Chief Tech/Sci/R&D Officer - 31/10/2016
Director TitleAgeSince
Chairman - 21/09/2014
Director/Board Member - 27/07/2004
Director/Board Member - 28/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
+3.46%+0.37%-25.69%-71.64% 24.29M
+0.48%-1.18%-40.03%-45.92% 606M
-1.25%+20.68%+126.61% - 401M
+2.82%+27.40%-31.27%+12.01% 122M
+5.74%+1.18%-1.15%+59.26% 94.9M
Average +2.25%+3.96%+5.69%-11.57% 249.66M
Weighted average by Cap. +0.61%+3.73%+17.59%-26.56%

Financials

2024 2025
Net sales 502M 15.56M 13.49M 12.63M 11.55M 21.78M 1.48B 22.15M 148M 57.98M 741M 58.41M 57.14M 2.47B 549M 17.04M 14.77M 13.83M 12.65M 23.84M 1.62B 24.25M 162M 63.48M 811M 63.96M 62.56M 2.7B
Net income -160M -4.96M -4.3M -4.03M -3.68M -6.94M -472M -7.06M -47.12M -18.48M -236M -18.62M -18.22M -786M -146M -4.54M -3.94M -3.69M -3.37M -6.36M -432M -6.47M -43.16M -16.93M -216M -17.06M -16.69M -720M
Net Debt 147M 4.54M 3.94M 3.69M 3.37M 6.36M 432M 6.47M 43.18M 16.94M 216M 17.06M 16.69M 720M 260M 8.07M 7M 6.55M 5.99M 11.29M 768M 11.49M 76.67M 30.07M 384M 30.3M 29.64M 1.28B
Logo Kim Forest Enterprise Co., Ltd.
KIM FOREST ENTERPRISE CO., LTD. is a Taiwan-based company mainly engaged in sale of biomedical products and provision of genetic testing and analysis services. The Company operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.
Employees
-
Date Price Change Volume
06/08/26 NT$13.45 +3.46% 5,301
05/08/26 NT$13.00 -1.14% 25,052
04/08/26 NT$13.15 +0.77% 44,505
03/08/26 NT$13.05 -2.25% 17,617
31/07/26 NT$13.35 +1.14% 43,035
  1. Stock Market
  2. Stocks
  3. 6645 Stock